FSD Pharma Inc (HUGE)

[Randy1111]

From FSD on X


In contemplating the notable journey of 2023, we are pleased to emphasize the substantial progress made in completing phase 1 trials for Lucid MS, our candidate drug for multiple sclerosis.

Additionally, we have collaborated with Celly Nu through Unbuzzd to address Alcohol Inebriation.

As we enter the approaching year, our dedication remains resolute in potentially transforming the perception and treatment of neurodegenerative disorders affecting brain health—benefiting patients, their families, and the broader communities.

We extend a sincere appreciation to all FSD Pharma shareholders and collaborators for your steadfast support. Thanks to your contributions, we are advancing toward a future where innovative therapies for multiple sclerosis and alcohol-related lifestyle beverages become attainable.

Happy New Years !!